Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2025 Report. https://goldcopd.org/2025-gold-report/

Barrecheguren M, Miravitlles M (2016) COPD heterogeneity: implications for management. Multidiscip Respir Med 11:14

Article  PubMed  PubMed Central  Google Scholar 

Woodruff PG, Agustí A, Roche N, Singh D, Martinez FJ (2015) Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet 385(9979):1789–1798

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cazzola M, Calzetta L, Rogliani P, Matera MG (2017) The challenges of precision medicine in COPD. Mol Diagn Ther 21(4):345–355

Article  CAS  PubMed  Google Scholar 

Agustí A, Barnes N, Cruz AA, Gibson PG, Heaney LG, Inoue H, Leather D, Martinez FJ, McDonald VM, Oppenheimer J, Papi A, Pavord ID, Thomas M, Walker S (2021) Yates L (2021) Moving towards a Treatable Traits model of care for the management of obstructive airways diseases. Respir Med 187:106572

Article  PubMed  Google Scholar 

McDonald VM, Fingleton J, Agustí A, Hiles SA, Clark VL, Holland AE, Marks GB, Bardin PP, Beasley R, Pavord ID, Wark PAB, Gibson PG (2019) Treatable traits: a new paradigm for 21st century management of chronic airway diseases: treatable traits down under international workshop report. Eur Respir J 53(5):1802058

Article  PubMed  Google Scholar 

Agustí A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, Humbert M, Jones P, Gibson PG, Vestbo J, Beasley R, Pavord ID (2016) Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J 47(2):410–419

Article  PubMed  Google Scholar 

Stolz D, Mkorombindo T, Schumann DM, Agustí A, Ash SY, Bafadhel M, Bai C, Chalmers JD, Criner GJ, Dharmage SC, Franssen FME, Frey U, Han M, Hansel NN, Hawkins NM, Kalhan R, Konigshoff M, Ko FW, Parekh TM, Powell P, Rutten-van Mölken M, Simpson J, Sin DD, Song Y, Suki B, Troosters T, Washko GR, Welte T, Dransfield MT (2022) Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet 400(10356):921–972

Article  PubMed  PubMed Central  Google Scholar 

Reddel HK, Gerhardsson de Verdier M, Agustí A, Anderson G, Beasley R, Bel EH, Janson C, Make B, Martin RJ, Pavord I, Price D, Keen C, Gardev A, Rennard S, Sveréus A, Bansal AT, Brannman L, Karlsson N, Nuevo J, Nyberg F, Young SS, Vestbo J (2019) Prospective observational study in patients with obstructive lung disease: NOVELTY design. ERJ Open Res 5(1):00036–02018

Article  PubMed  PubMed Central  Google Scholar 

Agustí A, Rapsomaniki E, Beasley R, Hughes R, Müllerová H, Papi A, Pavord ID, van den Berge M, Faner R (2022) Treatable traits in the NOVELTY study. Respirology 27(11):929–940

Article  PubMed  PubMed Central  Google Scholar 

Reddel HK, Vestbo J, Agustí A, Anderson GP, Bansal AT, Beasley R, Bel EH, Janson C, Make B, Pavord ID, Price D, Rapsomaniki E, Karlsson N, Finch DK, Nuevo J, de Giorgio-Miller A, Alacqua M, Hughes R, Müllerová H, Gerhardsson de Verdier M; NOVELTY study investigators (2021) Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort. Eur Respir J 58(3):2003927

Cardoso J, Ferreira AJ, Guimarães M, Oliveira AS, Simão P, Sucena M (2021) Treatable traits in COPD - a proposed approach. Int J Chron Obstruct Pulmon Dis 16:3167–3182

Article  PubMed  PubMed Central  Google Scholar 

Duszyk K, McLoughlin RF, Gibson PG, McDonald VM (2021) The use of treatable traits to address COPD complexity and heterogeneity and to inform the care. Breathe (Sheff) 17(4):210118

Article  PubMed  Google Scholar 

Marques A, Souto-Miranda S, Machado A, Oliveira A, Jácome C, Cruz J, Enes V, Afreixo V, Martins V, Andrade L, Valente C, Ferreira D, Simão P, Brooks D, Tavares AH (2022) COPD profiles and treatable traits using minimal resources: identification, decision tree and stability over time. Respir Res 23(1):30

Article  PubMed  PubMed Central  Google Scholar 

Sarwar MR, McDonald VM, Abramson MJ, Paul E, George J (2021) Treatable traits in an English cohort: prevalence and predictors of future decline in lung function and quality of life in COPD. ERJ Open Res 7(2):00934–02020

Article  PubMed  PubMed Central  Google Scholar 

Louis R, Louis G, Bonhomme O (2021) Novelty: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice. Eur Respir J 58(3):2100627

Article  PubMed  Google Scholar 

Hiles SA, Gibson PG, Agustí A, McDonald VM (2021) Treatable traits that predict health status and treatment response in airway disease. J Allergy Clin Immunol Pract 9(3):1255-1264.e2

Article  PubMed  Google Scholar 

Sarwar MR, McDonald VM, Abramson MJ, McLoughlin RF, Geethadevi GM, George J (2022) Effectiveness of interventions targeting treatable traits for the management of obstructive airway diseases: A systematic review and meta-analysis. J Allergy Clin Immunol Pract 10(9):2333-2345.e21

Article  PubMed  Google Scholar 

Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernández C, Alonso A, del Pozo F, de Toledo P, Antó JM, Rodríguez-Roisín R, Decramer M (2006) Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J 28(1):123–130

Article  CAS  PubMed  Google Scholar 

Garcia-Aymerich J, Hernandez C, Alonso A, Casas A, Rodriguez-Roisin R, Anto JM, Roca J (2007) Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med 101(7):1462–1469

Article  PubMed  Google Scholar 

McDonald VM, Higgins I, Wood LG, Gibson PG (2013) Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense? Thorax 68(7):691–694

Article  PubMed  Google Scholar 

Hernández C, Alonso A, Garcia-Aymerich J, Serra I, Marti D, Rodriguez-Roisin R, Narsavage G, Carmen Gomez M, Roca J (2015) Effectiveness of community-based integrated care in frail COPD patients: a randomised controlled trial. NPJ Prim Care Respir Med 25:15022

Article  PubMed  PubMed Central  Google Scholar 

Ko FW, Cheung NK, Rainer TH, Lum C, Wong I, Hui DS (2017) Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 72(2):122–128

Article  PubMed  Google Scholar 

Rose L, Istanboulian L, Carriere L, Thomas A, Lee HB, Rezaie S, Shafai R, Fraser I (2018) Program of integrated care for patients with chronic obstructive pulmonary disease and multiple comorbidities (PIC COPD+): a randomised controlled trial. Eur Respir J 51(1):1701567

Article  PubMed  Google Scholar 

Souto-Miranda S, Rocha V, Mendes MA, Simão P, Martins V, Spruit MA, Marques A (2023) The presence of extra-pulmonary treatable traits increases the likelihood of responding to pulmonary rehabilitation. Respir Med 206:107086

Article  PubMed  Google Scholar 

Thomas M, Beasley R (2023) The treatable traits approach to adults with obstructive airways disease in primary and secondary care. Respirology 28(12):1101–1116

Article  PubMed  Google Scholar 

Agustí A, Gibson PG, Heaney LG, Thomas M (2024) Change is in the air: key questions on the “Treatable Traits” model for chronic airway diseases in primary care. NPJ Prim Care Respir Med 34(1):21

Article  PubMed  PubMed Central  Google Scholar 

Matera MG, Calzetta L, Annibale R, Russo F, Cazzola M (2021) Classes of drugs that target the cellular components of inflammation under clinical development for COPD. Expert Rev Clin Pharmacol 14(8):1015–1027

Article  CAS  PubMed  Google Scholar 

Cazzola M, Hanania NA, Page CP, Matera MG (2023) Novel anti-inflammatory approaches to COPD. Int J Chron Obstruct Pulmon Dis 18:1333–1352

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barnes PJ (2017) Glucocorticosteroids. Handb Exp Pharmacol 237:93–115

Article  CAS  PubMed  Google Scholar 

Adcock IM, Bhatt SP, Balkissoon R, Wise RA (2022) The use of inhaled corticosteroids for patients with COPD who continue to smoke cigarettes: an evaluation of current practice. Am J Med 135(3):302–312

Article  CAS  PubMed  Google Scholar 

Matera MG, Page CP, Calzetta L, Rogliani P, Cazzola M (2020) Pharmacology and therapeutics of bronchodilators revisited. Pharmacol Rev 72(1):218–252

Article  CAS  PubMed